Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19
Xiaosheng Wu(Mayo Clinic), Thomas E. Witzig(WinnMed)
Cited by 17
Related Papers
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
|Leukemia|2010|299
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma
|Nature Genetics|2014|175
USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3/COL6A5 stabilisation
|Cell Death and Disease|2021|48